Industrial Doctorate Centre: Systems Approaches to Biomedical Science

拟议中的牛津工业生物医学科学系统方法博士学位的目标是确保英国在制药、生物医学、生物技术和生物医学相关IT领域拥有强大的未来创新者和研究领导者。它将建立在牛津大学现有的两个dtc（生命科学接口和系统生物学）的跨学科科学培训的记录和模式，以及我们现有的工业博士试点计划的基础上，提供一个全面的工业研究培训计划，根据每个学生的需求量身定制。并将与来自EPSRC医疗相关项目的国际领先的工业合作伙伴和学术团体进行合作。国际数据中心课程的毕业生将在授课课程和基于行业的研究项目中广泛接触其研究的工业背景。这将使他们能够发展项目管理、战略规划、领导能力、团队合作、商业意识和解决问题的技能，这些技能将需要将基础和医学科学的创新转化为商业产品开发。该提案得到了各相关工业部门（制药、生物医学和成像、与健康有关的信息技术和生物技术）的大力支持。支持这一提议的13家公司是：通用电气医疗集团（技术副总裁Jonathan Allis博士）；GSK （GSK临床影像中心副总裁兼主任Paul Matthews教授）；阿斯利康（高级科学技术实验室主任Andy Hargreaves博士）；罗氏（集团研究全球主管Bryn Roberts博士）；诺华（Ulrich Hummel博士，结构科学部门主管）；辉瑞（Ian Machin，疼痛发现生物学主任）；西门子分子成像（Jrme Declerck博士，科学与技术主管）、微软研究院（Stephen Emmott教授，外部研究主管）、飞利浦（Lothar Spies博士，数字成像主管）；富士通欧洲实验室（计算生物学主任Ross Nobes博士）、UCB Celltech（石继业博士）；Inhibox （Paul Finn博士）；和Summit （Richard Vickers, Drug Discovery）。上述各公司的代表所提供的支持函件，详列各公司将向数据中心提供的支援水平。其中几家公司将直接参与拟议的国际数据中心的教学计划。如果英国要保持在生物技术、生物医学和制药领域的领先地位，培养这些工业科学家至关重要。目前的经济状况给这些部门带来了财政压力，但是未来的创新和产品开发要求现在就开始培训这些未来的科学家。因此，EPSRC的支持至关重要。同样，拟议的培训和研究方案具有跨学科的性质，因此必须在培训方案中有大量的学生，他们可以相互支持和学习，而标准的博士培训路线根本无法实现国际数据中心的总体目标。

The goal of the proposed Oxford Industrial Doctorate in Systems Approaches to Biomedical Science is to ensure that the UK has a strong pipeline of future innovators and research leaders in the pharmaceutical, biomedical, biotechnology, and biomedically-related IT sectors. It will build on the track record and model of inter-disciplinary scientific training of the two existing DTCs in Oxford (at the Life Sciences Interface and in Systems Biology), and of our existing Industrial Doctorate pilot scheme, to provide a comprehensive industrial research training programme, tailored to the needs of each individual student, and will engage with internationally leading industrial partners and academic groups drawn from across the spectrum of EPSRC's healthcare-related programmes. Graduates from the IDC programme will receive extensive exposure to the industrial context of their research in both the taught programme and in their industry-based research projects. This will allow them to develop the skills in project management, strategic planning, leadership, team working, commercial awareness, and problem solving that will be required to translate innovations in basic and medical science into commercial product development.The proposal has very strong support from across the relevant industry sectors (pharmaceutical, biomedical and imaging, health-related IT and biotechnology). The 13 companies supporting this proposal are: GE Healthcare (Dr Jonathan Allis, Vice President for Technology); GSK (Professor Paul Matthews, Vice President, Imaging and Head, GSK Clinical Imaging Centre); AstraZeneca (Dr Andy Hargreaves, Director, Advanced Science and Technology Lab); Roche (Dr Bryn Roberts, Global Head of Group Research); Novartis (Dr Ulrich Hummel, Unit Head, Structural Sciences); Pfizer (Ian Machin, Director Pain Discovery Biology); Siemens Molecular Imaging (Dr. Jrme Declerck, Head of Science and Technology), Microsoft Research (Prof Stephen Emmott , Director of External Research), Philips (Dr Lothar Spies, Head of Digital Imaging); Fujitsu European Laboratory (Dr Ross Nobes, Head of Computational Biology), UCB Celltech (Dr Jiye Shi); Inhibox (Dr Paul Finn); and Summit (Richard Vickers, Drug Discovery). Full details of the levels of support to be provided to the IDC by each of these companies are given in the attached letters of support from each of the representatives listed above. Several of these companies will be directly involved in the teaching programme of the proposed IDC.Producing these industrial scientists is of paramount importance if the UK is to remain at the forefront of the biotechnology, biomedical and pharmaceutical sectors. Current economic conditions are resulting in financial pressures across these sectors, but future innovation and product development requires that the training of these future generations of scientists commences now. EPSRC support is therefore vital. Similarly, the interdisciplinary nature of the proposed training and research programmes necessitate a critical mass of students within the training programme who can support and learn from one another, and the overall goals of the IDC simply could not be met by the standard PhD training route.